{"id":"F2022L01391","name":"Statement of Principles concerning rotator cuff syndrome (Reasonable Hypothesis) (No. 109 of 2022)","slug":"statement-of-principles-concerning-rotator-cuff-syndrome-reasonable-hypothesis-no-109-of-2022","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"in_force","isInForce":true,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":441579,"registerId":"F2022L01391-fast-fetch-1775956845015","compilationNumber":null,"startDate":"2026-04-12","status":"InForce","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"Statement of Principles concerning rotator cuff syndrome (Reasonable Hypothesis) (No. 109 of 2022)","content":"---\nmeta-content-style-type: text/css\nmeta-content-type: application/xhtml+xml; charset=utf-8\nmeta-generator: Aspose.Words for .NET 22.10.0\n---\n\n?xml version=\"1.0\" encoding=\"utf-8\" standalone=\"no\"?>\n\n\n\n \n\nStatement of Principles\n\nconcerning\n\nROTATOR CUFF SYNDROME (Reasonable Hypothesis)\n\n(No. 109 of 2022)\n\nThe Repatriation Medical Authority determines the following Statement of Principles under subsection 196B(2) of the Veterans' Entitlements Act 1986.\n\n \n\nDated 21 October 2022.\n\n \n\n \n\n \n\n \n\n \n\n| The Common Seal of the Repatriation Medical Authority was affixed to this instrument at the direction of:
|\n| --- |\n|
Professor Terence Campbell AM
Chairperson
|\n\n\n \n\n \n\n\nContents\n\n1 Name\n\n2 Commencement\n\n3 Authority\n\n4 Repeal\n\n5 Application\n\n6 Definitions\n\n7 Kind of injury, disease or death to which this Statement of Principles relates\n\n8 Basis for determining the factors\n\n9 Factors that must exist\n\n10 Relationship to service\n\n11 Factors referring to an injury or disease covered by another Statement of Principles\n\nSchedule 1 - Dictionary\n\n1 Definitions\n\n \n\n\n\n\n1 Name\n\nThis is the Statement of Principles concerning rotator cuff syndrome (Reasonable Hypothesis) (No. 109 of 2022).\n\n2 Commencement\n\n This instrument commences on 21 November 2022.\n\n3 Authority\n\nThis instrument is made under subsection 196B(2) of the Veterans' Entitlements Act 1986.\n\n4 Repeal\n\nThe Statement of Principles concerning rotator cuff syndrome No. 100 of 2014 (Federal Register of Legislation No. F2014L01376) made under subsections 196B(2) and (8) of the VEA is repealed.\n\n5 Application\n\nThis instrument applies to a claim to which section 120A of the VEA or section 338 of the Military Rehabilitation and Compensation Act 2004 applies.\n\n6 Definitions\n\nThe terms defined in the Schedule 1 - Dictionary have the meaning given when used in this instrument.\n\n7 Kind of injury, disease or death to which this Statement of Principles relates\n\n(1) This Statement of Principles is about rotator cuff syndrome and death from rotator cuff syndrome.\n\nMeaning of rotator cuff syndrome\n\n(2) For the purposes of this Statement of Principles, rotator cuff syndrome:\n\n(a) means a clinically symptomatic inflammatory or degenerative disorder of the rotator cuff of the shoulder joint or the long head of biceps and their associated bursae; and\n\n(b) includes:\n\n(i) calcifying tendonitis of the shoulder;\n\n(ii) rotator cuff tear or rupture;\n\n(iii) rotator cuff impingement syndrome;\n\n(iv) rotator cuff tendinopathy or tendonitis;\n\n(v) subacromial impingement syndrome;\n\n(vi) supraspinatus syndrome; or\n\n(vii) tendonitis of the long head of the biceps; and\n\n(c) excludes adhesive capsulitis of the shoulder.\n\nNote 1: The rotator cuff is the musculotendinous cuff of the shoulder joint comprising supraspinatus, infraspinatus, subscapularis and teres minor muscles. Associated bursae include the subacromial or subdeltoid bursae.\n\nNote 2: Rotator cuff syndrome is characterised by persistent pain and tenderness in the shoulder that usually worsens when the arm is abducted into an overhead position.\n\n(3) While rotator cuff syndrome attracts ICD‑10‑AM codes M75.1, M75.2, M75.3, M74.4 or M74.5 in applying this Statement of Principles the meaning of rotator cuff syndrome is that given in subsection (2).\n\n(4) For subsection (3), a reference to an ICD-10-AM code is a reference to the code assigned to a particular kind of injury or disease in The International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification (ICD-10-AM), Tenth Edition, effective date of 1 July 2017, copyrighted by the Independent Hospital Pricing Authority, ISBN 978-1-76007-296-4.\n\nDeath from rotator cuff syndrome\n\n(5) For the purposes of this Statement of Principles, rotator cuff syndrome, in relation to a person, includes death from a terminal event or condition that was contributed to by the person's rotator cuff syndrome.\n\nNote: terminal event is defined in the Schedule 1 – Dictionary.\n\n8 Basis for determining the factors\n\nThe Repatriation Medical Authority is of the view that there is sound medical‑scientific evidence that indicates that rotator cuff syndrome and death from rotator cuff syndrome can be related to relevant service rendered by veterans, members of Peacekeeping Forces, or members of the Forces under the VEA, or members under the MRCA.\n\nNote: MRCA, relevant service and VEA are defined in the Schedule 1 – Dictionary.\n\n9 Factors that must exist\n\nAt least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting rotator cuff syndrome or death from rotator cuff syndrome with the circumstances of a person's relevant service:\n\n(1) having an injury to the affected shoulder within the 3 months before the clinical onset of rotator cuff syndrome;\n\nNote 1: Examples of activities or circumstances that can cause an injury to the affected shoulder include a fall, a violent pull or sudden traction injury, sports injury, a blow or direct trauma to the shoulder, lifting weights, and improperly administered vaccination to the shoulder.\n\nNote 2: injury to the affected shoulder is defined in the Schedule 1 – Dictionary.\n\n(2) undergoing a surgical procedure involving the affected shoulder joint before the clinical onset of rotator cuff syndrome;\n\n(3) performing any combination of:\n\n(a) repetitive or sustained activities of the affected shoulder when the shoulder on the affected side is abducted or flexed by at least 60 degrees; or\n\n(b) forceful activities with the affected upper limb;\n\nfor at least 80 hours within a period of 120 consecutive days before the clinical onset of rotator cuff syndrome, and where the repetitive or sustained or forceful activities have not ceased more than 30 days before the clinical onset of rotator cuff syndrome;\n\nNote: forceful activities are defined in the Schedule 1 - Dictionary.\n\n(4) performing repetitive or sustained activities of the affected shoulder when the shoulder on the affected side is abducted or flexed by at least 60 degrees for at least 2,000 hours within the 10 years before the clinical onset of rotator cuff syndrome;\n\nNote: Sports that require overhead activities (for example, tennis, swimming, and volleyball) often involve abduction or flexion of the shoulder by at least 60 degrees.\n\n(5) lifting or carrying loads of at least 20 kilograms using the upper limb of the affected side for at least 200 hours within the 10 years before the clinical onset of rotator cuff syndrome;\n\n(6) using a hand-held, vibrating, percussive, heavy industrial tool with the affected upper limb, for at least 2,000 hours within the 10 years before the clinical onset of rotator cuff syndrome;\n\n(7) having dialysis-related amyloidosis before the clinical onset of rotator cuff syndrome;\n\nNote: dialysis-related amyloidosis is defined in the Schedule 1 - Dictionary.\n\n(8) regularly using the upper limbs for weight-bearing for a continuous period of at least the 1 year before the clinical onset of rotator cuff syndrome;\n\nNote: Examples of circumstances in which the upper limbs may regularly be used for weight-bearing include transfers from a wheelchair to a chair or bed, and the use of crutches or other walking aids.\n\n(9) having anatomical narrowing of the subacromial space on the affected side at the time of the clinical onset of rotator cuff syndrome;\n\nNote: anatomical narrowing of the subacromial space is defined in the Schedule 1 - Dictionary.\n\n(10) having joint instability of the affected shoulder, or dislocation or subluxation of the affected shoulder joint before the clinical onset of rotator cuff syndrome;\n\n(11) having an infection of the subacromial bursa or subdeltoid bursa of the affected shoulder at the time of the clinical onset of rotator cuff syndrome;\n\n(12) having an autoimmune disease from the specified list of autoimmune diseases, involving the shoulder joint or associated bursae of the affected side, before the clinical onset of rotator cuff syndrome;\n\nNote: specified list of autoimmune diseases is defined in the Schedule 1 - Dictionary.\n\n(13) having gout involving the affected shoulder at the time of the clinical onset of rotator cuff syndrome;\n\n(14) having acquired scapular dyskinesis of the affected side at the time of the clinical onset of rotator cuff syndrome;\n\nNote: acquired scapular dyskinesis is defined in the Schedule 1 – Dictionary.\n\n(15) having smoked at least 20 pack-years of tobacco products before the clinical onset of rotator cuff syndrome;\n\nNote: one pack-year is defined in the Schedule 1 – Dictionary.\n\n(16) having diabetes mellitus before the clinical onset of rotator cuff syndrome;\n\n(17) having dyslipidaemia before the clinical onset of rotator cuff syndrome;\n\nNote: dyslipidaemia is defined in the Schedule 1 – Dictionary.\n\n(18) taking a glucocorticoid drug as specified before the clinical onset of rotator cuff syndrome;\n\nNote: taking a glucocorticoid drug as specified is defined in the Schedule 1 – Dictionary.\n\n(19) taking a fluoroquinolone antibiotic within the 60 days before the clinical onset of rotator cuff syndrome;\n\n(20) taking an aromatase inhibitor for at least 4 weeks within the 2 years before the clinical onset of rotator cuff syndrome;\n\nNote: Examples of aromatase inhibitors include anastrozole, exemestane and letrozole.\n\n(21) having an injury to the affected shoulder within the 3 months before the clinical worsening of rotator cuff syndrome;\n\nNote 1: Examples of activities or circumstances that can cause an injury to the affected shoulder include a fall, a violent pull or sudden traction injury, sports injury, a blow or direct trauma to the shoulder, lifting weights, and improperly administered vaccination to the shoulder.\n\nNote 2: injury to the affected shoulder is defined in the Schedule 1 – Dictionary.\n\n(22) undergoing a surgical procedure involving the affected shoulder joint before the clinical worsening of rotator cuff syndrome;\n\n(23) performing any combination of:\n\n(a) repetitive or sustained activities of the affected shoulder when the shoulder on the affected side is abducted or flexed by at least 60 degrees; or\n\n(b) forceful activities with the affected upper limb;\n\nfor at least 80 hours within a period of 120 consecutive days before the clinical worsening of rotator cuff syndrome, and where the repetitive or sustained or forceful activities have not ceased more than 30 days before the clinical worsening of rotator cuff syndrome;\n\nNote: forceful activities are defined in the Schedule 1 - Dictionary.\n\n(24) performing repetitive or sustained activities of the affected shoulder when the shoulder on the affected side is abducted or flexed by at least 60 degrees for at least 2,000 hours within the 10 years before the clinical worsening of rotator cuff syndrome;\n\nNote: Sports that require overhead activities (for example, tennis, swimming, and volleyball) often involve abduction or flexion of the shoulder by at least 60 degrees.\n\n(25) lifting or carrying loads of at least 20 kilograms using the upper limb of the affected side for at least 200 hours within the 10 years before the clinical worsening of rotator cuff syndrome;\n\n(26) using a hand-held, vibrating, percussive, heavy industrial tool with the affected upper limb, for at least 2,000 hours within the 10 years before the clinical worsening of rotator cuff syndrome;\n\n(27) having dialysis-related amyloidosis before the clinical worsening of rotator cuff syndrome;\n\nNote: dialysis-related amyloidosis is defined in the Schedule 1 - Dictionary.\n\n(28) regularly using the upper limbs for weight-bearing for a continuous period of at least the 1 year before the clinical worsening of rotator cuff syndrome;\n\nNote: Examples of circumstances in which the upper limbs may regularly be used for weight-bearing include transfers from a wheelchair to a chair or bed, and the use of crutches or other walking aids.\n\n(29) having anatomical narrowing of the subacromial space on the affected side at the time of the clinical worsening of rotator cuff syndrome;\n\nNote: anatomical narrowing of the subacromial space is defined in the Schedule 1 - Dictionary.\n\n(30) having joint instability of the affected shoulder, or dislocation or subluxation of the affected shoulder joint before the clinical worsening of rotator cuff syndrome;\n\n(31) having an infection of the subacromial bursa or subdeltoid bursa of the affected shoulder at the time of the clinical worsening of rotator cuff syndrome;\n\n(32) having an autoimmune disease from the specified list of autoimmune diseases, involving the shoulder joint or associated bursae of the affected side, before the clinical worsening of rotator cuff syndrome;\n\nNote: specified list of autoimmune diseases is defined in the Schedule 1 - Dictionary.\n\n(33) having gout involving the affected shoulder at the time of the clinical worsening of rotator cuff syndrome;\n\n(34) having acquired scapular dyskinesis of the affected side at the time of the clinical worsening of rotator cuff syndrome;\n\nNote: acquired scapular dyskinesis is defined in the Schedule 1 – Dictionary.\n\n(35) having smoked at least 20 pack-years of tobacco products before the clinical worsening of rotator cuff syndrome;\n\nNote: one pack-year is defined in the Schedule 1 – Dictionary.\n\n(36) having diabetes mellitus before the clinical worsening of rotator cuff syndrome;\n\n(37) having dyslipidaemia before the clinical worsening of rotator cuff syndrome;\n\nNote: dyslipidaemia is defined in the Schedule 1 – Dictionary.\n\n(38) taking a glucocorticoid drug as specified before the clinical worsening of rotator cuff syndrome;\n\nNote: taking a glucocorticoid drug as specified is defined in the Schedule 1 – Dictionary.\n\n(39) taking a fluoroquinolone antibiotic within the 60 days before the clinical worsening of rotator cuff syndrome;\n\n(40) taking an aromatase inhibitor for at least 4 weeks within the 2 years before the clinical worsening of rotator cuff syndrome;\n\nNote: Examples of aromatase inhibitors include anastrozole, exemestane and letrozole.\n\n(41) inability to obtain appropriate clinical management for rotator cuff syndrome.\n\n10 Relationship to service\n\n(1) The existence in a person of any factor referred to in section 9, must be related to the relevant service rendered by the person.\n\n(2) The factors set out in subsections 9(21) to 9(41)apply only to material contribution to, or aggravation of, rotator cuff syndrome where the person's rotator cuff syndrome was suffered or contracted before or during (but did not arise out of) the person's relevant service.\n\n11 Factors referring to an injury or disease covered by another Statement of Principles\n\nIn this Statement of Principles:\n\n(1) if a factor referred to in section 9 applies in relation to a person; and\n\n(2) that factor refers to an injury or disease in respect of which a Statement of Principles has been determined under subsection 196B(2) of the VEA;\n\nthen the factors in that Statement of Principles apply in accordance with the terms of that Statement of Principles as in force from time to time.\n\n \n\n \n\nSchedule 1 - Dictionary \n\nNote: See Section 6\n\n1 Definitions\n\nIn this instrument:\n\n acquired scapular dyskinesis means abnormal position or motion of the scapula, and may be evidenced clinically by winging of the scapula. Scapular dyskinesis occurs with injuries to the long thoracic and spinal accessory nerves (\"backpack palsy\") and space occupying lesions in the scapulothoracic area.\n\n anatomical narrowing of the subacromial space means an acquired reduction in the space between the coraco-acromial arch and the upper end of the humerus.\n\nNote: Examples of causes of acquired anatomical narrowing of the subacromial space include:\n\n(a) malunited fractures of the acromion, clavicle or greater tuberosity;\n\n(b) osteophytes or tumours projecting into the subacromial space; and\n\n(c) sutures, pins or wires from previous surgery.\n\n dialysis-related amyloidosis means beta2-microglobulin amyloidosis secondary to long-term haemodialysis or continuous ambulatory peritoneal dialysis.\n\n dyslipidaemia means persistently abnormal blood lipid levels, diagnosed by a medical practitioner and evidenced by:\n\n(a) a serum high density lipoprotein cholesterol level less than 1.0 mmol/L; or\n\n(b) a serum low density lipoprotein cholesterol level greater than 4.0 mmol/L; or\n\n(c) a serum triglyceride level greater than or equal to 2.0 mmol/L; or\n\n(d) total serum cholesterol level greater than 5.5 mmol/L; or\n\n(e) the regular administration of drug therapy to normalise blood lipid levels.\n\n forceful activities means tasks requiring the generation of force by the hand or arm:\n\n(a) equivalent to lifting or carrying loads of more than 3 kilograms; or\n\n(b) involving lifting or carrying an object greater than 1 kilogram in excess of 10 times per hour.\n\nNote 1: Use of crutches or other walking aids and hand propulsion of wheelchairs are included among the types of forceful activities that require generation of force by the hand or arm.\n\nNote 2: Sports that require overhead activities (for example, tennis, swimming, and volleyball) often involve abduction or flexion of the shoulder by at least 60 degrees.\n\n injury to the affected shoulder means an injury to the shoulder region that causes the development, within the 24 hours of the injury being sustained, of pain, tenderness, and altered mobility or range of movement of the shoulder joint. In the case of sustained unconsciousness or the masking of pain by analgesic medication, these symptoms and signs must appear on return to consciousness or the withdrawal of the analgesic medication. These symptoms and signs must last for a continuous period of at least 7 days following their onset, save for where medical intervention for the injury to that shoulder has occurred and that medical intervention involves either:\n\n(a) immobilisation of the shoulder by splinting, or similar external agent;\n\n(b) injection of corticosteroids or local anaesthetics into that shoulder; or\n\n(c) surgery to that shoulder.\n\n MRCA means the Military Rehabilitation and Compensation Act 2004.\n\n one pack-year means the amount of tobacco consumed in smoking 20 cigarettes per day for a period of 1 year, or an equivalent amount of tobacco products.\n\nNote 1: An equivalent amount of tobacco products is 7,300 grams of smoking tobacco by weight, either in cigarettes, pipe tobacco or cigars, or a combination of same. For pipe tobacco, cigars or combinations of multiple tobacco types, 1 gram of tobacco is considered to be equal to one cigarette.\n\nNote 2: Pack-years are calculated by dividing the number of cigarettes smoked per day by 20 and multiplying this number by the number of years the person has smoked. For example, smoking 10 cigarettes per day for 10 years is equal to 5 pack-years, and smoking 40 cigarettes per day for 10 years is equal to 20 pack-years.\n\n relevant service means:\n\n(a) operational service under the VEA;\n\n(b) peacekeeping service under the VEA;\n\n(c) hazardous service under the VEA;\n\n(d) British nuclear test defence service under the VEA;\n\n(e) warlike service under the MRCA; or\n\n(f) non-warlike service under the MRCA.\n\nNote: MRCA and VEA are also defined in the Schedule 1 - Dictionary.\n\n rotator cuff syndrome—see subsection 7(2).\n\n specified list of autoimmune diseases means:\n\n(a) dermatomyositis;\n\n(b) polymyalgia rheumatica;\n\n(c) polymyositis;\n\n(d) rheumatoid arthritis;\n\n(e) sicca syndrome;\n\n(f) Sjogren syndrome;\n\n(g) systemic lupus erythematosus; or\n\n(h) systemic sclerosis (scleroderma). \n\n taking a glucocorticoid drug as specified means:\n\n(a) taking prednisolone, in the combinations of mode of administration, dose, duration of treatment and proximity to the clinical onset or worsening of rotator cuff syndrome, as specified in Table 1 below; or\n\n(b) taking a glucocorticoid drug other than prednisolone, as specified in Table 1, and in doses having an efficacy equivalent to prednisolone, that being calculated for the drugs listed in accordance with Table 2 below.\n\nTable 1\n\n- Drug Mode Dose Minimum duration of treatment Proximity to clinical onset or worsening\n- Prednisolone IV, IM, O ≥ 0.5 grams over 6 months 6 months within the 3 years\n- ≥ 3 grams NS within the 5 years\n- ≥ 10 grams NS NS\n- Injection in tendonregion ≥ 1 injection NS within the 2 weeks\n\n\nAbbreviations: IV = intravenous; IM = intramuscular;\n\nO = oral; NS = not specified.\n\nTable 2\n\n| Glucocorticoid drug | Dose efficacy equivalence to prednisolone |\n| --- | --- |\n| cortisone | 5 |\n| hydrocortisone | 4 |\n| prednisolone | 1 |\n| prednisone | 1 |\n| methylprednisolone | 0.8 |\n| triamcinolone | 0.8 |\n| paramethasone | 0.4 |\n| dexamethasone | 0.15 |\n| betamethasone | 0.12 |\n\n\n \n\n terminal event means the proximate or ultimate cause of death and includes the following:\n\n(a) pneumonia;\n\n(b) respiratory failure;\n\n(c) cardiac arrest;\n\n(d) circulatory failure; or\n\n(e) cessation of brain function.\n\n VEA means the Veterans' Entitlements Act 1986.\n\n \n\n \n","sortOrder":0}],"analysis":{"flash_summary":{"complexity_score":6,"scope_assessment":{"changed":true,"description":"Compared with an earlier Statement that this instrument repeals (No. 100 of 2014 — s4), this instrument shows substantive changes that broaden and make more granular the medical and exposure pathways that can support a reasonable hypothesis of service‑relatedness. Concrete changes apparent in the text include: the addition or explicit statement of drug exposures as qualifying factors (fluoroquinolones, aromatase inhibitors, detailed glucocorticoid dose/duration/proximity rules — s9(18)–(20) and Schedule glucocorticoid tables); explicit inclusion of non‑mechanical risk factors such as dyslipidaemia, diabetes, dialysis‑related amyloidosis and a defined list of autoimmune diseases (s9(7), s9(12), s9(16)–(17) and Schedule); the separate, mirrored treatment of initial clinical onset and clinical worsening/aggravation (s9(1)–(20) vs s9(21)–(41)); and an express factor for inability to obtain appropriate clinical management (s9(41)). These additions and the instrument’s detailed numeric thresholds (hours, weights, pack‑years, drug windows) make the test both broader in the kinds of medical contributors recognised and more prescriptive in evidentiary terms than a simpler, less‑specified original instrument would have been. The result is a scope that is larger in medical mechanisms covered and more granular in the evidentiary criteria claimants must meet."},"complexity_factors":["41 alternative factors listed in section 9 (s9(1)–s9(41)), many duplicated for onset and for clinical worsening","Schedule 1 with multiple technical definitions (acquired scapular dyskinesis, anatomical narrowing, dialysis-related amyloidosis, dyslipidaemia, forceful activities, injury to the affected shoulder, pack‑year, specified autoimmune diseases, taking a glucocorticoid drug as specified, terminal event, etc.) — ~15–20 defined terms","Multiple quantitative exposure thresholds and time windows (e.g. 80 hours/120 days; 2,000 hours/10 years; 200 hours/10 years; 60 days; 4 weeks/2 years; 3 months; 30 days) across different factors","Glucocorticoid dosing table plus equivalence table (Table 1 and Table 2 in Schedule 1) requiring dose conversion and proximity criteria","Cross‑references to ICD‑10‑AM codes (s7(3)–(4)) and to other Statements of Principles (s11)","Conditional logic separating initial clinical onset factors from material contribution/aggravation factors (s9(1)–(20) vs s9(21)–(41)) and added requirement that any factor be related to relevant service (s10)","Defined clinical thresholds (e.g. dyslipidaemia numeric cut‑offs) that require laboratory evidence (Schedule)","Repeal and replacement of a previous Statement (s4) — potentially requiring comparison to prior text in application and interpretation"],"plain_english_summary":"**What this instrument does (mechanically)**\n\n- This is a Statement of Principles made by the Repatriation Medical Authority (RMA) under the Veterans' Entitlements Act. It sets out the specific medical and exposure factors that, if present, are sufficient to raise a \"reasonable hypothesis\" that a person’s rotator cuff syndrome (RCS) — or death where RCS contributed — is related to their relevant military service (see s3, s7, s9). \n\n- The document lists a set of alternative factors. At least one of those factors must be present for a claim to meet the RMA’s medical threshold for connection to service (s9). Those factors include recent shoulder injury or surgery, defined patterns of physical work or sport, particular medical conditions, and certain drug exposures (s9(1)–(41)). \n\n- Some factors are expressed as exposure thresholds with precise time windows and quantities (for example, 80 hours in 120 days, 2,000 hours in 10 years, lifting 20 kg for 200 hours in 10 years — see s9(3), s9(4), s9(5)). Others are clinical findings or diagnoses (for example, anatomical narrowing of the subacromial space, joint instability, dialysis‑related amyloidosis, diabetes, dyslipidaemia — see s9(9), s9(10), s9(7), s9(16), s9(17)). \n\n- The Statement distinguishes factors that support an initial causal link to service (s9(1)–(20)) from those that may materially contribute or aggravate an existing RCS where the condition was suffered or contracted before or during (but not arising out of) service (s9(21)–(41)). The presence of any listed factor must itself be related to the person’s relevant service (s10). \n\n- The instrument also defines RCS for the purposes of claims, including a list of included shoulder diagnoses and one specific exclusion (adhesive capsulitis) and notes corresponding ICD‑10‑AM codes but clarifies the statutory meaning is the definition in s7(2) (s7(2)–(4)). It includes death from RCS where RCS contributed to the terminal event (s7(5)). Definitions and technical thresholds used in the factors are set out in Schedule 1 (definitions for forceful activities, pack‑years, specified autoimmune diseases, glucocorticoid dose equivalences, etc.).\n\n**Who is affected**\n\n- Veterans and former members covered by the Veterans’ Entitlements Act 1986 (VEA) and members covered by the Military Rehabilitation and Compensation Act 2004 (MRCA) making claims where section 120A of the VEA or section 338 of the MRCA applies (s5, Schedule definition of relevant service). \n\n- Medical practitioners, case managers and decision‑makers who assess service‑relatedness in claims for compensation or entitlements. \n\n- Claimants who must marshal medical records, employment/service history and other evidence (timing, doses, hours worked, surgery, imaging) to show that at least one factor in s9 applies and that it is related to their service (s9, s10, Schedule definitions).\n\n**Why it matters (purpose claimed by the RMA and how the instrument implements that purpose)**\n\n- The RMA states it has \"sound medical‑scientific evidence\" that RCS can be related to relevant service (s8). To implement that claim, the instrument translates the scientific findings into a set of concrete, legally‑operative factors and thresholds that lower the evidentiary hurdle from proving causation on the balance of probabilities to establishing a \"reasonable hypothesis\" for administrative decision‑making (mechanism: s9 and s10). \n\n- The practical effect is procedural: if a claimant can show one of the listed factors (and link it to service), decision‑makers can accept a service relationship without requiring more intensive causal proof. That determines whether a medical condition meets the statutory gateway for further consideration of entitlements under the VEA/MRCA.\n\n**Testing the stated purpose against likely costs, incentives and implementation trade‑offs**\n\n- Evidence burden and compliance costs: Many factors require documentary proof that may be administrative or medical (surgery records, employment or training logs showing hours of overhead activity, imaging confirming anatomical narrowing, prescription records for specific drugs and doses, pack‑year calculations for smoking). That increases the evidentiary burden on claimants and on decision makers to verify detailed thresholds (see s9 and Schedule 1). \n\n- Precision vs. disputability: The instrument’s detailed quantitative thresholds (e.g. 80 hours/120 days, 2,000 hours/10 years, 200 hours/10 years; drug windows such as fluoroquinolone within 60 days) reduce ambiguity but create discrete pass/fail lines that can be litigated or contested when records are incomplete (s9(3)–(6), s9(19), s9(20), Schedule table for glucocorticoids). \n\n- Scope of covered mechanisms: The Statement explicitly includes multiple non‑mechanical contributors (diabetes, dyslipidaemia, smoking ≥20 pack‑years, specific drugs, dialysis‑related amyloidosis) as independent factors (s9(15)–(19), s9(7), s9(16)–(17)). That broadens medical pathways that can support claims but requires medical documentation and sometimes laboratory thresholds (Schedule definitions for dyslipidaemia). \n\n- Incentives for record‑keeping and behaviour: The detailed thresholds create an incentive for claimants and clinicians to document work tasks, exposures and drug use precisely. Employers/units are not directly altered by the instrument, but better documentation of duties and exposures will assist claimants. \n\n- Administrative cost and capacity: Decision‑makers must assess many discrete biochemical, pharmacological and occupational criteria. That increases processing complexity and may raise administrative costs (clinical review, requests for historical records, occupational exposure assessments). \n\n- Risk of substitution or evidentiary gaps: Where a claimant cannot meet a precise hours/dose threshold because of missing records, an otherwise plausible service link could fail to satisfy the statutory \"reasonable hypothesis.\" That is an implementation risk arising from rigid thresholds (s9 and Schedule definitions). \n\n- Limited scope for regulatory discretion: The Statement prescribes the factors that will satisfy the RMA’s test. While decision‑makers still assess whether a factor is related to service (s10), the RMA’s approach narrows clinical discretion by listing qualifying mechanisms and thresholds.\n\n**Key practical points for claimants and practitioners**\n\n- Show at least one qualifying factor from s9 and tie that factor to the person’s relevant service (s10). \n- Prepare to produce clinical notes, imaging, surgical records, prescription records and service/activity logs to meet the numerical and timing requirements in s9 and the Schedule. \n- Note the instrument treats initial clinical onset and clinical worsening separately (s9(1)–(20) vs s9(21)–(41)). Some factors apply to both; others are framed for aggravation of pre‑existing RCS.\n\n**Where to look in the instrument**\n\n- Definition and scope of RCS: s7 (including ICD‑10‑AM cross‑reference in s7(3)–(4)). \n- The list of qualifying factors and precise thresholds: s9 and the Schedule definitions that give technical meaning to terms like \"forceful activities\", \"pack‑year\", and the glucocorticoid tables. \n- Relation to service and distinction between contribution and aggravation: s10 and s9(21)–(41). \n- Definitions and dose equivalence rules (glucocorticoid table and equivalents): Schedule 1."},"flash_summary_failed":{"failed":true,"reason":"Unauthenticated. Configure AI_GATEWAY_API_KEY or use a provider module. Learn more: https://ai-sdk.dev/unauthenticated-ai-gateway","source":"analysis-cron"},"kimi_summary":{"content_quality":"ok","complexity_score":6,"scope_assessment":{"changed":false,"description":"This instrument maintains the established scope of Repatriation Medical Authority Statements of Principles. It replaces the 2014 version (No. 100 of 2014) with updated medical evidence and refined definitions, but does not expand beyond the traditional purpose of establishing service-connection factors for a specific medical condition. The structure remains consistent with the standard template: definition of condition, basis for determination, enumerated factors with temporal qualifiers, relationship to service provisions, and definitional schedule."},"complexity_factors":["41 distinct factors with specific temporal requirements (e.g., 'within 3 months', 'at least 2,000 hours within 10 years', 'continuous period of at least 1 year')","14 defined terms in Schedule 1, several with nested sub-definitions and clinical thresholds (e.g., dyslipidaemia requires specific blood test values or medication use)","Complex pharmaceutical definitions requiring cross-referencing to conversion tables (Table 1 and Table 2 for glucocorticoid equivalency calculations)","Dual structure mirroring onset vs. worsening factors (factors 1-20 vs. 21-40) with subtle variations in application rules under section 10(2)","Cross-referencing mechanism in section 11 that incorporates other Statements of Principles dynamically ('as in force from time to time')","Anatomical and medical terminology requiring specialist knowledge (e.g., 'abducted or flexed by at least 60 degrees', 'subacromial space', 'scapulothoracic area')","Mathematical calculations required for pack-years of smoking and glucocorticoid dose equivalencies"],"plain_english_summary":"This instrument lists 41 medical and lifestyle factors that create a \"reasonable hypothesis\" a veteran’s rotator cuff syndrome is connected to Australian Defence Force service, so claimants may get the benefit of the doubt for compensation or treatment. It affects current/former ADF members, veterans and peacekeepers claiming under the Veterans' Entitlements Act 1986 or the Military Rehabilitation and Compensation Act 2004, and updates the 2014 guidance."}},"importantCases":[],"_links":{"self":"/api/acts/statement-of-principles-concerning-rotator-cuff-syndrome-reasonable-hypothesis-no-109-of-2022","history":"/api/acts/statement-of-principles-concerning-rotator-cuff-syndrome-reasonable-hypothesis-no-109-of-2022/history","analysis":"/api/acts/statement-of-principles-concerning-rotator-cuff-syndrome-reasonable-hypothesis-no-109-of-2022/analysis","conflicts":"/api/acts/statement-of-principles-concerning-rotator-cuff-syndrome-reasonable-hypothesis-no-109-of-2022/conflicts","importantCases":"/api/acts/statement-of-principles-concerning-rotator-cuff-syndrome-reasonable-hypothesis-no-109-of-2022/important-cases","documents":"/api/acts/statement-of-principles-concerning-rotator-cuff-syndrome-reasonable-hypothesis-no-109-of-2022/documents"}}